Periplogenin alleviates osteoarthritis by suppressing NF-κB-mediated inflammation and apoptosis in chondrocytes
International Immunopharmacology · 2026
DOI: 10.1016/j.intimp.2026.116296 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Zhonghua Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Cheeloo College of Medicine, Shandong Universit…. Hauptthemen laut MEDLINE: Chondrocytes, NF-kappa B, Osteoarthritis, Anti-Inflammatory Agents. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoarthritis (OA), a prevalent chronic degenerative disorder among middle-aged and elderly populations, is closely linked to inflammatory responses and subsequent extracellular matrix degradation. This condition causes significant patient suffering and imposes substantial socioeconomic burdens. Current therapies primarily focus on symptomatic relief (pain reduction and functional improvement), lacking targeted approaches addressing OA's underlying pathophysiological processes, while drug-related adverse effects remain problematic. Periplogenin, a natural compound with documented anti-inflammatory and anti-tumor properties, has garnered increasing attention; however, its potential role in OA pathogenesis is unexplored. This study first investigated periplogenin's effects on primary murine chondrocytes. Utilizing multiple experimental approaches, we demonstrated that periplogenin effectively attenuates TNF-α-induced inflammation, apoptosis, and consequent metabolic imbalance in chondrocytes. Furthermore, in a murine OA model, periplogenin administration conferred protective effects in vivo, mitigating OA progression. RNA sequencing analysis suggested suppression of the NF-κB signaling pathway as the potential mechanism, which was subsequently validated through both cellular and animal-level experiments. Collectively, our findings establish that periplogenin alleviates OA by inhibiting the NF-κB pathway, thereby reducing inflammation and chondrocyte apoptosis. This study identifies periplogenin as a promising candidate and provides a novel therapeutic strategy for targeted OA intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China; Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
- Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China; Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
- Department of Pediatric Surgery, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
- Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Department of Anaesthesia, National Center for Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
- Department of Orthopedic Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, Z., Li, J., Wang, Q., Zhang, S., Li, Y., Jin, S., Wang, Z., Chen, J., Yang, W., Liu, T., Wang, X., Qiu, C., Zhang, F., & Wang, Y. (2026). Periplogenin alleviates osteoarthritis by suppressing NF-κB-mediated inflammation and apoptosis in chondrocytes. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.116296
Vancouver
Zhou Z, Li J, Wang Q, Zhang S, Li Y, Jin S, et al. Periplogenin alleviates osteoarthritis by suppressing NF-κB-mediated inflammation and apoptosis in chondrocytes. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.116296
BibTeX
@article{Zhou2026,
author = {Zhou, Zhonghua and Li, Jinxu and Wang, Qiong and Zhang, Shengling and Li, Yang and Jin, Shaobin and Wang, Zhe and Chen, Junfei and Yang, Weiwei and Liu, Tianyi and Wang, Xinyu and Qiu, Cheng and Zhang, Fan and Wang, Yawen},
title = {Periplogenin alleviates osteoarthritis by suppressing NF-κB-mediated inflammation and apoptosis in chondrocytes},
journal = {International Immunopharmacology},
year = {2026},
doi = {10.1016/j.intimp.2026.116296}
}
EUVIMED